Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
NCT01652326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 792
Last updated 2016-01-13
Summary
The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
Conditions
- Alcohol Withdrawal Syndrome
Interventions
- DRUG
-
Diazepam
Sponsors & Collaborators
-
Hospira, now a wholly owned subsidiary of Pfizer
collaborator INDUSTRY -
University of Pittsburgh
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- United States
Study Locations
More Related Trials
-
Drug Therapy for Alcohol Detoxification
NCT00000441 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
NCT02242955 ·Status: COMPLETED ·Phase: NA
-
Remote Treatment of Alcohol Withdrawal
NCT04858490 ·Status: COMPLETED ·Phase: NA
-
Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
NCT00721526 ·Status: COMPLETED ·Phase: PHASE4
-
Treating Alcohol Withdrawal With Oral Baclofen
NCT00597701 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
NCT00523185 ·Status: COMPLETED ·Phase: NA
-
Fixed-schedule Benzodiazepine Dosing vs Based on a CIWA-Ar Alcohol Protocol in Alcohol Detoxification.
NCT04777552 ·Status: COMPLETED
-
Assessment of Valproate on Ethanol Withdrawal
NCT03235531 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Valproate on Benzodiazepine Withdrawal Severity
NCT00570219 ·Status: COMPLETED ·Phase: NA
-
Study of DCR-AUD in Healthy Volunteers
NCT05021640 ·Status: COMPLETED ·Phase: PHASE1
-
Baclofen in Managing Acute Alcohol Withdrawal
NCT03293017 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
NCT03877120 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
NCT01076283 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetic Treatments for Alcoholism
NCT01591291 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Alcohol Biosensor Monitoring for Alcoholic Liver Disease
NCT03533660 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA
-
Testing Doxazosin to Treat Stress Mechanisms in Alcoholism
NCT02989493 ·Status: COMPLETED ·Phase: PHASE2
-
Outpatient Treatment of Alcohol Withdrawal Syndrome
NCT00136617 ·Status: COMPLETED ·Phase: PHASE3
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of the Medication Prazosin for Alcohol Dependence
NCT00762710 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02275611 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
NCT04793685 ·Status: RECRUITING ·Phase: PHASE2
-
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
NCT00585780 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
NCT03253926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2